Amgen completes $27.8b acquisition of Horizon Therapeutics
Amgen Inc., a US biotechnology company, completed the acquisition of Horizon Therapeutics Plc for $27.8 billion, gaining access to the Dublin-based firm’s two.
Drugs
Health
Pharma
Drugs
Pharma
Amgen to buy Dublin-based Horizon for $27.8 billion
Amgen Inc, one of the world's largest biotechnology companies, will acquire Dublin-based Horizon Therapeutics Plc for $27.8 billion.